Evercore ISI Group Maintains In-Line on Moderna, Raises Price Target to $35

Moderna +4.26%

Moderna

MRNA

52.84

+4.26%

Evercore ISI Group analyst Cory Kasimov maintains Moderna (NASDAQ: MRNA) with a In-Line and raises the price target from $28 to $35.